How much of the regional variation in RRT incidence rates within the UK is explained by the health needs of the general population?

被引:11
作者
Castledine, Clare I. [1 ]
Gilg, Julie A. [1 ]
Rogers, Chris [2 ]
Ben-Shlomo, Yoav [3 ]
Caskey, Fergus J. [2 ,4 ]
机构
[1] Southmead Hosp, UK Renal Registry, Bristol, Avon, England
[2] Univ Bristol, Sch Clin Sci, Bristol, Avon, England
[3] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England
[4] Southmead Hosp, Richard Bright Renal Unit, Bristol, Avon, England
关键词
access to healthcare; diabetes; hypertension; incidence; renal replacement therapy; STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; REPLACEMENT THERAPY; MYOCARDIAL-INFARCTION; ENGLAND; PREVALENCE; RISK; ESRD; PROGRESSION; EUROPE;
D O I
10.1093/ndt/gfs294
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Variation in end-stage renal disease treatment rates in the UK persist after adjustment for socio-demographic factors. Methods. UK-wide ecological study using population socio-demographic factors, health status characteristics and access to health services factor in to explain the incidence of renal replacement therapy (RRT). Results. There was a 6% higher incidence rate of RRT per standard deviation (SD) increase in area diabetes prevalence after adjustment for area level socio-economic deprivation status and the proportion of non-white residents [incidence rate ratio adjusted (IRR adjusted) 1.06 (95% confidence interval 1.03,1.09), P < 0.001]. A 3% lower-adjusted RRT incidence rate was seen with each SD higher proportion of diabetics achieving an HbA1c of <7.5% [IRR 0.97 (0.94, 1.00), P = 0.03]. Hypertension prevalence was independently associated with an 8% higher RRT incidence rate per SD increase [IRR adjusted 1.08 (1.04, 1.11), P < 0.001] and an SD increase in life expectancy in an area was independently associated with 7% lower RRT incidence rate [IRR adjusted 0.93 (0.91, 0.96), P < 0.001]. An SD increase in premature cardiovascular (CV) mortality rate in an area was also independently associated with RRT incidence rates [IRR adjusted 1.06 (1.03, 1.09), P < 0.001]. Rates of coronary artery bypass grafting (CABG)/angioplasty and knee replacement were positively associated with RRT incidence, but mammography uptake was not associated. In total, 31% of the regional variation in RRT incidence could be explained by these factors. Conclusions. Diabetes prevalence, the proportion of diabetics achieving good glycaemic control, hypertension prevalence, life expectancy, premature CV mortality, CABG/angioplasty and knee replacement rates were all associated with RRT incidence. A third of the regional variation in RRT incidence between areas can be explained by these demographic, health and access to health services factors.
引用
收藏
页码:3943 / 3950
页数:8
相关论文
共 41 条
  • [1] Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease
    Agarwal, Rajiv
    Bunaye, Zerihun
    Bekele, Dagim M.
    Light, Robert P.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2008, 28 (04) : 569 - 575
  • [2] [Anonymous], RENAL VASCULAR DIS
  • [3] [Anonymous], RENAL VASCULAR DIS
  • [4] [Anonymous], 6 UK REN REG
  • [5] [Anonymous], ENGLISH INDICES DEPR
  • [6] Progress in retarding the progression of advanced chronic kidney disease: Grounds for optimism
    Batlle, D.
    Ramadugu, P.
    Soler, M. J.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 : S40 - S44
  • [7] Temporal decline in the prognostic impact of a recurrent acute myocardial infarction 1985 to 2002
    Buch, P.
    Rasmussen, S.
    Gislason, G. H.
    Rasmussen, J. N.
    Kober, L.
    Gadsboll, N.
    Stender, S.
    Madsen, M.
    Torp-Pedersen, C.
    Abildstrom, S. Z.
    [J]. HEART, 2007, 93 (02) : 210 - 215
  • [8] UK Renal Registry 12th Annual Report (December 2009): Chapter 3 UK ESRD Incident Rates in 2008: national and centre-specific analyses
    Byrne, Catherine
    Ford, Daniel
    Gilg, Julie
    Ansell, David
    Feehally, John
    [J]. NEPHRON CLINICAL PRACTICE, 2010, 115 : C9 - C39
  • [9] Global variation in renal replacement therapy for end-stage renal disease
    Caskey, Fergus J.
    Kramer, Anneke
    Elliott, Robert F.
    Stel, Vianda S.
    Covic, Adrian
    Cusumano, Ana
    Geue, Claudia
    MacLeod, Alison M.
    Zwinderman, Aeilko H.
    Stengel, Benedicte
    Jager, Kitty J.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (08) : 2604 - 2610
  • [10] Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales
    Caskey, FJ
    Schober-Halstenberg, HJ
    Roderick, PJ
    Edenharter, G
    Ansell, D
    Frei, U
    Feest, TG
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (03) : 445 - 454